Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Validation of the EBMT risk score in chronic myeloid leukemia in Brazil and allogeneic transplant outcome.
De Souza CA, Vigorito AC, Ruiz MA, Nucci M, Dulley FL, Funcke V, Tabak D, Azevedo AM, Byington R, Macedo MC, Saboya R, Penteado Aranha FJ, Oliveira GB, Zulli R, Martins Miranda EC, Azevedo WM, Lodi FM, Voltarelli JC, Simões BP, Colturato V, De Souza MP, Silla L, Bittencourt H, Piron-Ruiz L, Maiolino A, Gratwohl A, Pasquini R. De Souza CA, et al. Among authors: vigorito ac. Haematologica. 2005 Feb;90(2):232-7. Haematologica. 2005. PMID: 15710577
Brazilian experience using high dose sequential chemotherapy followed by autologous hematopoietic stem cell transplantation for malignant lymphomas.
Duarte BK, Miranda EC, Nucci M, Vigorito AC, Penteado FJ, Marques JF Jr, Oliveira-Duarte GB, Lorand-Metze IG, Pagnano KB, Delamain MT, Baldissera R, Valente IS, de Souza CA. Duarte BK, et al. Among authors: vigorito ac. Rev Bras Hematol Hemoter. 2011;33(6):432-8. doi: 10.5581/1516-8484.20110118. Rev Bras Hematol Hemoter. 2011. PMID: 23049359 Free PMC article.
Brazilian experience using high-dose sequential chemotherapy followed by autologous hematopoietic stem cell transplantation for relapsed or refractory Hodgkin lymphoma.
Duarte BK, Valente I, Vigorito AC, Aranha FJ, Oliveira-Duarte G, Miranda EC, Lorand-Metze I, Pagnano KB, Delamain M, Marques Junior JF, Brandalise SR, Nucci M, De Souza CA. Duarte BK, et al. Among authors: vigorito ac. Clin Lymphoma Myeloma. 2009 Dec;9(6):449-54. doi: 10.3816/CLM.2009.n.088. Clin Lymphoma Myeloma. 2009. PMID: 19951885
73 results